Deep Phenotyping of Cutaneous Lupus Erythematosus

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Cutaneous Lupus Erythematosus

Interventions

DRUG

IMIQUIMOD cream 50mg/g

5 mg imiquimod (100mg Aldara®) per treatment site with a 12mm Finn chamber

Trial Locations (1)

RECRUITING

Centre for Human Drug Research, Leiden

All Listed Sponsors

lead

Centre for Human Drug Research, Netherlands

OTHER